Biotech

All Articles

Lilly blog posts a lot more favorable records on its own weekly insulin prospect

.On the heels of an FDA turndown for its main competing Novo Nordisk, Eli Lilly is actually gaining ...

IN 8bio halts stage 2 trial, gives up one-half of labor force

.Merely a few months after application the first person in a phase 2 trial for newly diagnosed gliob...

Lilly, Haya ink $1B biobuck weight problems pact to explore darker genome

.Eli Lilly's look for weight problems intendeds has led it to the darker genome. The Big Pharma has ...

ArsenalBio elevates $325M, rotates out of previous lead resource

.Collection Biosciences is going on up. The tissue treatment business has actually added $325 thousa...

Lilly- backed weight-loss biotech files IPO

.After raising $170 thousand back in February, metabolic disease-focused BioAge Labs has submitted t...

Aelis' cannabis usage medication fails phase 2b, driving Indivior to re-think $100M option

.Aelis Farma's hopes of protecting a fast, positive selection on a $one hundred thousand option sett...

ProKidney standstills phase 3 test not needed to have for cell therapy permission

.ProKidney has actually stopped one of a set of phase 3 tests for its tissue therapy for renal condi...

Vaxcyte rises on 'sensational' 31-valent PCV succeed against Pfizer

.Vaxcyte introduced what experts referred to as "spectacular" stage 1/2 data for its own 31-valent p...

Recursion's mind health condition test shows little proof of effectiveness

.Recursion has actually stumbled through a very early examination of its tech-enabled approach to dr...

Acepodia, Pfizer click with each other for chemistry-based tissue treatment

.Call it an instance of great chemistry: Acepodia, a biotech based upon Nobel Prize-winning scientif...